Alkem Laboratories Ltd - 539523 - Closure of Trading Window
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th March, 2020 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March, 2020 are communicated to the Stock Exchanges. Alkem Laboratories Ltd - 539523 - Clarification sought from Alkem Laboratories Ltd
The Exchange has sought clarification from Alkem Laboratories Ltd with respect to news article appearing on economictimes.indiatimes.com March 13, 2020 titled "CCI asks Alkem Labs, Macleods Pharma, BCDA not to indulge in unfair biz practices".The reply is awaited.
Alkem Labs gets EIR from USFDA for Baddi facility
The Baddi facility was inspected by the United States Food and Drug Administration (USFDA) from February 17 to 21, 2020, Alkem Laboratories said in a filing to BSE. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In furtherance lo the intimation captioned "US FDA Inspection at Alkem''s manufacturing facility located at Baddi, India" dated 21 st February, 2020, this is to inform you that US FDA has issued an Establishment Inspection Report (EIR) for the Company''s manufacturing facility located at Baddi, India which was inspected from 17th February, 2020 to 21 st February, 2020. The inspection has now been closed by the US FDA. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In furtherance lo the intimation captioned "US FDA Inspection at Alkem''s manufacturing facility located at Baddi, India" dated 21 st February, 2020, this is to inform you that US FDA has issued an Establishment Inspection Report (EIR) for the Company''s manufacturing facility located at Baddi, India which was inspected from 17th February, 2020 to 21 st February, 2020. The inspection has now been closed by the US FDA. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Directorate
This is to inform you that the tenure of Mr. Akhouri Maheshwar Prasad, Independent Director of the Company shall expire on 15th March, 2020, and on completion of his tenure, he shall cease to be the Director on the Board of Alkem Laboratories Limited. Kindly take the same on your records. Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In furtherance to our intimation dated 7th February,2020, this is to inform you that the Company is in the process of conducting postal ballot including voting by electronic means) for seeking approval of members of the Company for businesses as specified in the Postal Ballot Notice dated 7th February,2020. In terms of Reg 30 of SEBI (LODR) Reg, 2015, please find enclosed the Postal Ballot Notice dated 7th February,2020 along with the Postal Ballot Form. In this connection, please note that the voting would commence on Friday, 6th March, 2020 at 9.00 am and shall remain open for a period of 30 days i.e. till Saturday, 4th, April, 2020 at 5.00 pm. CS Manish L. Ghia, Partner, M/s Manish Ghia & Associates, Company Secretaries, Mumbai has been appointed as Scrutinizer for conducting Postal Ballot process in fair and transparent manner. Kindly take note of the same. Alkem Labs gets 2 USFDA observations for Baddi facility
Drug firm Alkem Laboratories on Friday said it has received two observations from the US health regulator after inspection of its Baddi facility in H Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to inform you that US FDA had conducted an inspection at the Company's manufacturing facility located at Baddi, India from 17th February, 2020 to 21st February, 2020. At the end of inspection, the Company has received a Form 483 with two (2) observations. The Company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA observations and the same is proposed to be filed within the timeline stipulated by US FDA. Kindly take note of the same.
Alkem Labs share price gains 2% on nod for Baddi unit
German drug regulator had audited Alkem's Baddi unit on November 26, 2019.